Glass Laser Multiplexed Biosensor: a short and didactic video by ULB
26 Ene 16
The project GLAM, standing for Glass Laser Multiplexed Biosensor, is presenting a video to explain in a simple and didactic
The project GLAM, standing for Glass Laser Multiplexed Biosensor, is presenting a video to explain in a simple and didactic
An online networking tool is now available to proposers to find potential partners for proposing a project under the Horizon
«Health, Demographic Change & Wellbeing» challenge in Horizon 2020 Do you intend to prepare a proposal for the challenge in
Oryzon published on the 29th of December 2015 a press release regarding the public funding it has received for research
Developing new therapies for Batten disease www.batcure.eu ABSTRACT The goal of BATCure is to advance the development of new therapeutic
Through its expert in Health issues, LEITAT is attending today the Personalised Health TechMeeting in Paris. The project GLAM was
On the 13th of January 2016, we will attend the European Health Brokerage Event in Paris. Our health expert will
RESTORATION project has released its newsletter! Click here to download it. It is all about Resorbable Ceramic Biocomposites! You will
On 29-30th October Vision2020, in collaboration with MedCity and Research Media, will be hosting Health Tech 2020 at London City Hall.
LEITAT Foundation, FC Barcelona Foundation and Bioiberica S.A, a biotechnology company specialised in arthritis and health, have joined forces to
LEITAT is boosting a community in the Health’s industries sector about Technologies for Health, which met in Terrassa on the
El proyecto de investigación aplicada ToxAb tiene por objetivo principal generar una ventaja competitiva en el área de la terapia
There is nothing very glamorous about cancer, but now a new EU-funded project – GLAM – aims to help make
During the PEGS 2015, the Toxab project presented a poster about recombinant antibodies for research, diagnosis and therapy. Antibodies are
GLAM Glass-Laser Multiplexed Biosensor glam-project.eu Differential cancer diagnosis takes place daily in clinical settings for a better monitoring of patient
DENECOR Devices for NeuroControl and NeuroRehabilitation www.denecor.info ABSTRACT DeNeCor addresses the diagnosis and treatment of neurological diseases, which have an
Sede Central Leitat
C/ de la Innovació, 2
08225 Terrassa, (Barcelona)
Tel. (+34) 937 882 300
